The modified light chain of inter-alpha inhibitor/antibody fusion protein, MR1007, improves survival in the rabbit sepsis models

par Nakamura, Masaki, Takeuchi, Takashi, Yatagai, Yukiko, Naito, Katsuki, Shirakawa, Kamon, Hosaka, Yoshitaka, Furusako, Shoji
Publié 2007

In vivo Antitumor Mechanism of Natural Human Tumor Necrosis Factor Involving a T Cell‐mediated Immunological Route

par Asami, Tetsuya, Imai, Meroni, Tanaka, Yasuo, Hosaka, Yoshitaka, Kato, Kazuharu, Nakamura, Norio, Horisawa, Yoshifumi, Ashida, Yoshikazu, Kanamori, Toshinori, Nobuhara, Masahiro, Kurimoto, Masashi
Publié dans Jpn J Cancer Res (1989)

A novel free fatty acid receptor 1 (GPR40/FFAR1) agonist, MR1704, enhances glucose‐dependent insulin secretion and improves glucose homeostasis in rats

par Tsuda, Naoto, Kawaji, Atsuko, Sato, Toshihiro, Takagi, Mitsuhiro, Higashi, Chika, Kato, Yutaka, Ogawa, Kumiko, Naba, Hiroyasu, Ohkouchi, Munetaka, Nakamura, Masaki, Hosaka, Yoshitaka, Sakaki, Junichi
Publié dans Pharmacol Res Perspect (2017)

A novel antiplatelet antibody therapy that induces cAMP-dependent endocytosis of the GPVI/Fc receptor γ-chain complex

par Takayama, Hiroshi, Hosaka, Yoshitaka, Nakayama, Kazuyuki, Shirakawa, Kamon, Naitoh, Katsuki, Matsusue, Tomokazu, Shinozaki, Mikihiko, Honda, Motoyasu, Yatagai, Yukiko, Kawahara, Tetsushi, Hirose, Jiro, Yokoyama, Tooru, Kurihara, Michiru, Furusako, Shoji
Publié 2008